Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.6301
-0.0161 (-2.49%)
At close: Sep 16, 2025, 4:00 PM EDT
0.6430
+0.0129 (2.05%)
After-hours: Sep 16, 2025, 7:53 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.74 million as of September 16, 2025. Its market cap has decreased by -87.06% in one year.
Market Cap
2.74M
Enterprise Value
-872.69K
1-Year Change
-87.06%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.74M, a decrease of -98.68%. That is a compound annual growth rate of -74.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 2.81M | -71.28% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |